AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Belite Bio, Inc American Depositary Shares
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG016LJYTW4
147.33▼ 2.94 (-1.96%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
150.27
Day's Range
146.27 – 150.70
52-Week Range
89.16 – 200.00
Volume
49.5K
Avg Volume
146.4K
Share Statistics
Shares Outstanding
Employees
41
Exchange
XNAS
Listed
2022-04-29
Share count as of December 31, 2025

Belite Bio, Inc American Depositary Shares (BLTE) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Belite Bio, Inc American Depositary Shares (BLTE)
What is Belite Bio, Inc American Depositary Shares's Market Cap?
Belite Bio, Inc American Depositary Shares's Market Cap is $5.8B, based on as-reported figures from SEC (XBRL) filings.
What is Belite Bio, Inc American Depositary Shares's Enterprise Value?
Belite Bio, Inc American Depositary Shares's Enterprise Value is $5.4B, based on as-reported figures from SEC (XBRL) filings.
What is Belite Bio, Inc American Depositary Shares's EV / EBITDA?
Belite Bio, Inc American Depositary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Belite Bio, Inc American Depositary Shares's Net Income (TTM)?
Belite Bio, Inc American Depositary Shares's Net Income (TTM) is -$77.6M, based on as-reported figures from SEC (XBRL) filings.
What is Belite Bio, Inc American Depositary Shares's EBITDA?
Belite Bio, Inc American Depositary Shares's EBITDA is -$84.0M, based on as-reported figures from SEC (XBRL) filings.
What is Belite Bio, Inc American Depositary Shares's Diluted EPS (TTM)?
Belite Bio, Inc American Depositary Shares's Diluted EPS (TTM) is -1.97, based on as-reported figures from SEC (XBRL) filings.
What is Belite Bio, Inc American Depositary Shares's Net Debt?
Belite Bio, Inc American Depositary Shares's Net Debt is -$352.9M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · BLTEAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020
Expenses
Research and development
Selling, general and administrative
Total operating expenses
Loss from operations
Other income (expense):
Interest income
Interest expense
Other income (expense)
Total other income, net
Loss before income tax
Income tax expense
Net loss
Basic (in dollar per share)
Diluted (in dollar per share)